Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults

被引:55
作者
Corneli, Ginevra [1 ]
Di Somma, Carolina [2 ]
Prodam, Flavia [1 ]
Bellone, Jaele [3 ]
Bellone, Simonetta [1 ]
Gasco, Valentina [3 ]
Baldellis, Roberto [4 ,6 ]
Rovere, Silvia [3 ]
Schneider, Harald Joern [3 ]
Gargantini, Luigi [5 ]
Gastaldi, Roberto
Ghizzoni, Lucia [7 ]
Valle, Domenico [8 ]
Salerno, Mariacarolina [9 ]
Colao, Annamaria [2 ]
Bona, Gianni [1 ]
Ghigo, Ezio [3 ]
Maghnie, Mohamad [6 ]
Aimaretti, Gianluca [1 ]
机构
[1] Amedeo Avogadro Univ Novara, Dept Clin & Expt Med, Div Pediat, I-28100 Novara, Italy
[2] Univ Naples Federico II, Dept Endocrinol, I-80100 Naples, Italy
[3] Univ Turin, Div Endocrinol & Metab Dis, I-10100 Turin, Italy
[4] Regina Elena Inst Canc Res, Serv Endocrinol, I-00100 Rome, Italy
[5] Hosp Treviglio, Div Pediat Endocrinol, I-24047 Treviglio, Italy
[6] Univ Genoa, IRCCS G Gaslini, Dept Pediat, I-16100 Genoa, Italy
[7] Univ Parma, Div Pediat, I-8100 Parma, Italy
[8] Eli Lilly & Co, Florence, Italy
[9] Univ Naples Federico II, Dept Pediat, Naples, Italy
关键词
D O I
10.1530/EJE-07-0384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To define the appropriate diagnostic cut-off limits for the GH response to GHRH+arginine (ARG) test and IGF-I levels, using receiver operating characteristics (ROC) curve analysis, in late adolescents and young adults. Design and methods: We studied 152 patients with childhood-onset organic hypothalamic-pituitary disease (85 males, age (mean +/- S.E.M.): 19.2 +/- 0.2 years) and 201 normal adolescents as controls (96 males, age: 20.7 0.2 years). Patients were divided into three subgroups on the basis of the number of the other pituitary hormone deficits, excluding GH deficiency (GHD): subgroup A consisted of 35 panhypopituitary patients (17 males, age: 21.2 +/- 0.4 years), subgroup B consisted of 18 patients with only one or with no more than two pituitary hormone deficits (7 males, age: 20.2 +/- 0.9 years); and subgroup C consisted of 99 patients without any known hormonal pituitary deficits (60 males, age: 18.2 +/- 0.2 years). Both patients and controls were lean (body mass index, BMI < 25 kg/m(2)). Patients in subgroup A were assumed to be GHD, whereas in patients belonging to subgroups B and C the presence of GHD had to be verified. Results: For the GHRH+ARG test, the best pair of highest sensitivity (Se; 100%) and specificity (Sp; 97%) was found choosing a peak GH of 19.0 mu g/l. For IGF-I levels, the best pair of highest Se (96.6%) and Sp (74.6%) was found using a cut-off point of 160 mu g/l(SDS: -1.3). Assuming 19.0 mu g/l to be the cut-off point established for GHRH+ARG test, 72.2%, of patients in subgroup B and 39.4% in subgroup C were defined as GHD. In patients belonging to group B and C and with a peak GH response < 19 mu g/l to the test, IGF-I levels were lower than 160 mu g/l (or less than 1.3 SDS) in 68.7 and 41.6% of patients respectively predicting severe GHD in 85.7% of panhypopituitary patients (subgroup A). Conclusions: In late adolescent and early adulthood patients, a GH cut-off limit using the GHRH+ARG test lower than 19.0 mu g/l is able to discriminate patients with a suspicion of GHD and does not vary from infancy to early adulthood.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 37 条
[1]   Update on the diagnosis of GH deficiency in adults [J].
Abs, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 :S3-S8
[2]   IGFs and IGFBPs in adult growth hormone deficiency [J].
Aimaretti, G ;
Baldelli, R ;
Corneli, G ;
Croce, C ;
Rovere, S ;
Baffoni, C ;
Bellone, S ;
Gasco, V ;
Granata, R ;
Grottoli, S ;
Ghigo, E .
IGF-I and IGF Binding Proteins: Basic Research and Clinical Management, 2005, 9 :76-88
[3]   Insulin-like growth factor I levels and the diagnosis of adult growth hormone deficiency [J].
Aimaretti, G ;
Corneli, G ;
Rovere, S ;
Granata, R ;
Baldelli, R ;
Grottoli, S ;
Ghigo, E .
HORMONE RESEARCH, 2004, 62 :26-33
[4]  
Aimaretti G, 2001, J Pediatr Endocrinol Metab, V14 Suppl 5, P1233
[5]   Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone plus arginine as provocative tests for the diagnosis of GH deficiency in adults [J].
Aimaretti, G ;
Corneli, G ;
Razzore, P ;
Bellone, S ;
Baffoni, C ;
Arvat, E ;
Camanni, F ;
Ghigo, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) :1615-1618
[6]   Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency [J].
Aimaretti, G ;
Corneli, G ;
Baldelli, R ;
Di Somma, C ;
Gasco, V ;
Durante, C ;
Ausiello, L ;
Rovere, S ;
Grottoli, S ;
Tamburrano, G ;
Ghigo, E .
CLINICAL ENDOCRINOLOGY, 2003, 59 (01) :56-61
[7]   Comparisons among old and new provocative tests of GH secretion in 178 normal adults [J].
Aimaretti, G ;
Baffoni, C ;
DiVito, L ;
Bellone, S ;
Grottoli, S ;
Maccario, M ;
Arvat, E ;
Camanni, F ;
Ghigo, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142 (04) :347-352
[8]   Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test [J].
Aimaretti, G ;
Baffoni, C ;
Bellone, S ;
Di Vito, L ;
Corneli, G ;
Arvat, E ;
Benso, L ;
Camanni, F ;
Ghigo, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3693-3699
[9]  
Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379
[10]   Confirmation of severe GH deficiency after final height in patients diagnosed as GH deficient during childhood [J].
Attanasio, AF ;
Howell, S ;
Bates, PC ;
Blum, WF ;
Frewer, P ;
Quigley, C ;
Shalet, SM .
CLINICAL ENDOCRINOLOGY, 2002, 56 (04) :503-507